Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible light Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113444041A details a mild, blue LED-driven route to quinolines. This metal-free process offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112812060B reveals a metal-free, visible-light driven arylation method for tetrahydroquinoline derivatives, offering green synthesis routes for pharmaceutical intermediates.
Novel photocatalytic route offers high purity and green manufacturing advantages for pharmaceutical intermediates supply chains globally.
Novel visible light method for deuterated aromatics using arylthianthrene salts. Metal-free, high yield, cost-effective for pharma intermediates.
Patent CN113045479B details a green FeCl3-catalyzed route for 3-hydroxyisoindol-1-ones, offering cost-effective API intermediate manufacturing solutions.
Patent CN107353245B reveals metal-free photocatalytic route. Delivers high purity quinoline intermediates with significant supply chain and cost advantages for global buyers.
Discover a green, visible-light mediated method for synthesizing phosphorylated quinazolinone compounds. This novel route offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN117924125B details metal-free visible light synthesis for sulfonamide derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105503742A reveals visible light photocatalysis for high-yield difluoroalkyl uracil synthesis offering supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN112390696B reveals a safe, metal-free method for alpha-aminonitrile synthesis using benzoyl cyanide and visible light, offering significant cost and safety advantages.
Novel photocatalytic method using acetone eliminates expensive metals. Ideal for API intermediates manufacturing with reduced costs and simplified supply chains.
Patent CN111253254A details a green CuCl2-catalyzed dichlorination method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN111253254B details a mild visible light method for dichloride synthesis using CuCl2. This offers cost reduction in fine chemical manufacturing and reliable supply.
Novel photocatalytic synthesis route for high-purity phenanthridine derivatives. Green chemistry approach ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN107899611B details bifunctional catalysts combining cinchona alkaloids and porphyrins for visible-light driven asymmetric synthesis, offering greener pharmaceutical intermediate production.
Patent CN111072555A details a green HEH-catalyzed method for heterocyclic sulfones, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN110386885A enables metal-free visible light synthesis of β-carbonyl sulfones. Achieve cost reduction in fine chemical manufacturing with scalable, green protocols.
Patent CN115611756B reveals visible light catalysis for glycine derivatives, offering cost reduction in agrochemical manufacturing and high-purity supply chain solutions.
Patent CN115611756B reveals a visible-light photocatalytic method for α-substituted glycine derivatives, offering mild conditions and scalable agrochemical intermediate manufacturing.
Patent CN116283699B reveals a visible-light driven method for high-purity fluoroalkyl pyrrolidines offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.